Anixa Biosciences, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.10 | $-0.07 | +30.0% | Beat |
| Q22026 FY2026 | $-0.10 | $-0.09 | +10.0% | Beat |
| Q22026 FY2026 | $-0.10 | $-0.09 | +10.0% | Beat |
| 2026-03-10 | $-0.09 | — | — | Miss |
Back to ANIX overview · ANIX holders · ANIX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.